DM for medical students

DM for medical students

University

10 Qs

quiz-placeholder

Similar activities

Fun Facts about Sleep!

Fun Facts about Sleep!

University

11 Qs

Diabetes mellitus II

Diabetes mellitus II

University

10 Qs

Fungsi Homeostasis dalam Tubuh

Fungsi Homeostasis dalam Tubuh

University

6 Qs

Kimia Klinik

Kimia Klinik

University

12 Qs

Examen clase 13

Examen clase 13

University

10 Qs

ME 529 Diabetes 1 Quiz

ME 529 Diabetes 1 Quiz

University

10 Qs

Quiz sobre Diabetes Mellitus

Quiz sobre Diabetes Mellitus

University

10 Qs

pretest blok 7 angkatan 2024

pretest blok 7 angkatan 2024

University

10 Qs

DM for medical students

DM for medical students

Assessment

Quiz

Health Sciences

University

Hard

Created by

ดารารัตน์ undefined

Used 3+ times

FREE Resource

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In a patient with T2DM and established atherosclerotic cardiovascular disease (ASCVD) or high ASCVD risk, which drug class should be considered first?

Metformin

Sulfonylureas

GLP-1 RA or SGLT2i

DPP-4 Inhibitors

Answer explanation

In patients with T2DM and high ASCVD risk, GLP-1 receptor agonists (RA) or SGLT2 inhibitors (i) are preferred first-line due to their cardiovascular benefits, regardless of initial HbA1c levels.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which diabetes medication is most associated with a high risk of hypoglycemia?

Metformin

SGLT2i

Sulfonylureas

DPP-4 Inhibitors

Answer explanation

Sulfonylureas are known to stimulate insulin release from the pancreas, which can lead to a significant risk of hypoglycemia. In contrast, Metformin, SGLT2 inhibitors, and DPP-4 inhibitors have a lower risk of causing low blood sugar.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which diabetes medication should be avoided in patients with heart failure?

Thiazolidinediones

Metformin

GLP-1 RA

SGLT2i

Answer explanation

Thiazolidinediones should generally be avoided in patients with heart failure with reduced ejection fraction (HFrEF) due to their potential to cause fluid retention, worsening heart failure symptoms.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following is NOT a common side effect of Metformin?

Nausea

Weight gain

Lactic acidosis

Diarrhea

Answer explanation

Weight gain is not a common side effect of Metformin; in fact, it often leads to weight loss. Nausea, diarrhea, and lactic acidosis are known side effects associated with this medication.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following is NOT a recognized benefit of SGLT2 Inhibitors?

Cardiovascular disease (CVD) risk reduction

Improvement in insulin sensitivity in peripheral tissues

Reduction in heart failure (HF) hospitalization

Slowing of chronic kidney disease (CKD) progression

Answer explanation

SGLT2 inhibitors primarily benefit cardiovascular health, heart failure, and kidney function. They do not significantly improve insulin sensitivity in peripheral tissues, making this the correct choice.

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

According to current guidelines, what is the most common initial insulin type recommended for patients with Type 2 Diabetes when insulin therapy is needed?

Basal insulin

Premixed insulin

Mealtime (bolus) insulin

Intravenous insulin

Answer explanation

Current guidelines widely recommend initiating basal insulin as the first step for most Type 2 Diabetes patients requiring insulin, due to its effectiveness in controlling fasting glucose.

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following statements is NOT generally true about DPP-4 Inhibitors?

They carry a high risk of hypoglycemia as monotherapy.

They primarily work by enhancing incretin hormone effects.

They are oral medications.

They are weight-neutral.

Answer explanation

DPP-4 inhibitors do not carry a high risk of hypoglycemia as monotherapy, making this statement NOT generally true. They enhance incretin effects, are oral medications, and are considered weight-neutral.

Create a free account and access millions of resources

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

By signing up, you agree to our Terms of Service & Privacy Policy

Already have an account?